IgM anti-GM3 antibodies (intravenous) (Chugai)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameIgM anti-GM3 antibodies (intravenous) (Chugai)
Drug Alias Namehexamer L-612CA-19L-612CJ-45
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunoglobulin M agonistsGanglioside GM3 modulators
TargetsImmunoglobulin M
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChugai Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChugai Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A